Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2005
08/18/2005US20050181380 reacting a biological molecule sample with an organic electrolluminescence dye (EL-dye) and measuring the fluorescence of the biological molecule sample labeled with the organic EL-dye
08/18/2005US20050181379 Method and device for isolating and positioning single nucleic acid molecules
08/18/2005US20050181378 For PCR and DNA sequencing; electrophoresis; microfluidics
08/18/2005US20050181377 Database for use in comparative genomic hybridization and tumor diagnosis; bioinformatics; antitumor agents
08/18/2005US20050181375 Using presence of metastatic lung cancer-associated transcripts as diagnostic tool in diagnosis, prognosis and characterization of cell proliferative disorders
08/18/2005US20050181374 Kruppel-like factor 6 ( KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein
08/18/2005US20050181373 Determining alleles of gene encoding micromolar calcium activated neutral protease by assaying sample of nucleic acids; detecting mutants; selecting cattle for breeding
08/18/2005US20050181371 Expression vector comprising nucleotide sequences coding tyrosine kinase binding protrein for use in identifying modulator for prevention and treatment of muscular and respiratory disorders
08/18/2005US20050181370 Using non-testis tumor markers to diagnose/prognose cell proliferative disorders; monitoring efficacy of antitumor treatments
08/18/2005US20050181369 Compositions and methods for diagnostics and therapeutics for hydrocephalus
08/18/2005US20050181368 Protein for use in hypoxia related conditions
08/18/2005US20050181367 Method of concentrating macromolecules or agglomerates of molecules or particles
08/18/2005US20050181366 Molecular switches and methods for making and using the same
08/18/2005US20050181364 Assay
08/18/2005US20050181363 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith
08/18/2005US20050181362 Aligning the test nuclear receptor (NR) polypeptide, with at least one reference NR polypeptide sequence for which an X-ray structure is available; building a three-dimensional model for the test NR polypeptide, examining the three-dimensional model of the test NR polypeptide sequence for difference
08/18/2005US20050181361 Computer model for diagnosis/prognosis of hapatocyte cell proliferative disorders
08/18/2005US20050181357 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection
08/18/2005US20050181356 Hepatitis c virus assay systems
08/18/2005US20050181355 Compositions and methods for the modulation of viral maturation
08/18/2005US20050181354 Methods of assaying physiological states
08/18/2005US20050180994 or drug targets; determining a candidate's effect on ubiquitin ligase activity of the poxviral p28 polypeptide; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) treatment; side effect reduction of vaccination
08/18/2005US20050180993 Assays for the identification of compounds that inhibit assembly of nucleoprotein (NP), virion-associated proteins VP35, and VP24, or inhibit the glycosylation of NP, required for nucleocapsid formation, for use as anti-viral agents
08/18/2005US20050180992 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product
08/18/2005US20050180984 Modulating vaccine against HIV-1 Nef protein induced lymphocyte depletion
08/18/2005US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy
08/18/2005US20050180981 Human checkpoint kinase, hCDS1, compositions and methods
08/18/2005US20050180973 TREM-1 splice variant for use in modifying immune responses
08/18/2005US20050180949 hC1Q/TNF7 and uses thereof
08/18/2005DE10354207B3 Verfahren zum Nachweis von pathologisch veränderten Prion-Proteinen (PrPSc) und Kit zur Durchführung des Verfahrens A method for detecting pathologic prion proteins (PrPSc) and Kit for performing the method
08/18/2005DE102004005497A1 Method for diagnosing uniparental disomy, e.g. growth retardation or Prader-Willi syndrome, by comparing informative single-nucleotide polymorphisms in a subject with those in its parents
08/18/2005DE102004004924A1 A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson A141S and G399S mutation in the Omi / HtrA2 protein in Parkinson's disease
08/18/2005DE102004004894A1 Identifying substances that regulate PIM kinases, useful for treatment and diagnosis of urinary incontinence and the urge to urinate, and similar use of PIM proteins or nucleic acids
08/18/2005DE102004004882A1 Testsystem und Verfahren zum Nachweis von Analyten Test system and method for detecting analytes
08/18/2005DE102004003860A1 Verfahren zur Geno- und Pathotypisierung von Pseudomonas aeruginosa A method for geno- and pathotyping of Pseudomonas aeruginosa
08/18/2005DE102004001959A1 Mittel zur Indentifizierung von Risikopersonen für das Auftreten des Phänomens des "plötzlichen Einschlafens" Means for identification of persons at risk for the occurrence of the phenomenon of "sudden sleep"
08/18/2005CA2791798A1 New primers and probes for the detection of parvovirus b19
08/18/2005CA2585231A1 Self-assembling split-fluorescent protein systems
08/18/2005CA2560055A1 Method of inducing or modulating immune response
08/18/2005CA2559949A1 New primers and probes for the detection of parvovirus b19
08/18/2005CA2555965A1 Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
08/18/2005CA2555680A1 Method for testing or screening for an enzyme of interest
08/18/2005CA2555632A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005CA2555469A1 Use of relaxin-3 for promoting food intake, increasing body weight gain, increasing fat weight and for others
08/18/2005CA2555463A1 Inhibitors of tgf-r signaling for treatment of cns disorders
08/18/2005CA2555346A1 Method of detecting nucleic acid and utilization thereof
08/18/2005CA2555083A1 Genes associated with canine osteoarthritis and related methods and compositions
08/18/2005CA2555081A1 High throughput device for performing continuous-flow reactions
08/18/2005CA2554845A1 A method for the simultaneous determination of blood group and platelet antigen genotypes
08/18/2005CA2554780A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
08/18/2005CA2554779A1 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
08/18/2005CA2554775A1 Naphthalimide dosing by n-acetyl transferase genotyping
08/18/2005CA2554441A1 Detection of biological and chemical agents
08/18/2005CA2554431A1 Genetic markers for skatole metabolism
08/18/2005CA2554362A1 Treatment of neurodegenerative diseases by the use of atp7a inhibitors
08/18/2005CA2554218A1 Screening assays
08/18/2005CA2553928A1 Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment
08/18/2005CA2553683A1 Detection of ruminant dna via pcr
08/18/2005CA2553270A1 Detection, identification and differentiation of proteus species using the spacer region
08/18/2005CA2553040A1 Modified human four helical bundle polypeptides and their uses
08/18/2005CA2553035A1 Modified human growth hormone polypeptides and their uses
08/18/2005CA2553034A1 Modified human interferon polypeptides and their uses
08/18/2005CA2552955A1 Induction of apoptosis via arts-iap complexes
08/18/2005CA2551781A1 Improved fertility restoration for ogura cytoplasmic male sterile brassica and method
08/18/2005CA2497245A1 Test element with a one layer reaction film
08/17/2005EP1564780A2 Apparatus for determining molecular weight of polymers
08/17/2005EP1564557A1 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
08/17/2005EP1564306A2 Methods for fragmenting and labeling DNA
08/17/2005EP1564305A2 Means for detecting and treating cancer cells resistant to therapeutic agents
08/17/2005EP1564304A1 Method of DNA array construction, gene expression analysis, and discovery of useful genes
08/17/2005EP1564303A2 Strand displacement amplification of RNA targets
08/17/2005EP1564302A1 Genes for diagnosing colorectal cancer
08/17/2005EP1564301A1 Method of amplifying nucleic acid
08/17/2005EP1564300A1 Hethod of amplifying nucleic acid and apparatus therefor
08/17/2005EP1564299A1 Method of screening for compounds that inhibit the enzymatic activity of gwt1 gene product
08/17/2005EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease
08/17/2005EP1564290A2 Nucleic acid ligands of tissue targets
08/17/2005EP1564289A1 Stabilization of linear double-stranded DNA in the presence of exonucleases
08/17/2005EP1564287A1 Method of predicting genetic risk for hypertension
08/17/2005EP1563727A1 Methods for coupling resistance alleles in tomato
08/17/2005EP1563545A2 Method for creating a functional interface between a nanoparticle, nanotube or nanowire, and a biological molecule or system
08/17/2005EP1563444A2 Method for producing virtual chromosomes
08/17/2005EP1563419A2 Method for predicting the formation of mould fungi
08/17/2005EP1563302A2 Methods for selecting treatment regimens and predicting outcomes in cancer patients
08/17/2005EP1563275A2 Nanomotion sensing system and method
08/17/2005EP1563101A1 Method for the identification of sulfo-reducing bacteria
08/17/2005EP1563100A2 Displacement sandwich immuno-pcr
08/17/2005EP1563099A1 Induction of the mitochondrial permeability transition
08/17/2005EP1563098A2 Gene expression in biological conditions
08/17/2005EP1563097A2 Sampling method and apparatus for amplification reaction analysis
08/17/2005EP1563096A2 Methods and compositions for detecting telomerase activity
08/17/2005EP1563095A2 Microarray-based method for amplifying and detecting nucleic acids during a continuous process
08/17/2005EP1563093A1 Method of identifying and assessing dna euchromatin for detecting disease
08/17/2005EP1563092A2 Assays and methods based on microcompetition with a foreign polynucleotide
08/17/2005EP1563091A2 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems
08/17/2005EP1563090A2 Methods, compositions and computer software products for interrogating sequence variations in functional genomic regions
08/17/2005EP1563089A2 Solid phase based nucleic acid assays combining high affinity and high specificity
08/17/2005EP1563088A1 Agents and methods for detecting human adenoviruses
08/17/2005EP1563087A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a)
08/17/2005EP1563086A1 Device for determining the activity of enzymes